CORONA Remedies rises on getting GMP certification from Brazilian Health Regulatory Agency
CORONA Remedies is currently trading at Rs. 2040.00, up by 21.50 points or 1.07% from its previous closing of Rs. 2018.50 on the BSE.
The scrip opened at Rs. 2025.05 and has touched a high and low of Rs. 2046.25 and Rs. 2003.00 respectively. So far 538 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2285.00 on 15-Sep-2026 and a 52 week low of Rs. 1336.95 on 23-Dec-2025.
Last one week high and low of the scrip stood at Rs. 2,051.50 and Rs. 1990.60 respectively. The current market cap of the company is Rs. 12455.86 crore.
The promoters holding in the company stood at 69.00%, while Institutions and Non-Institutions held 20.66% and 10.34% respectively.
CORONA Remedies has received Good Manufacturing Practice (GMP) Compliance Certification from Brazilian Health Regulatory Agency, ANVISA, Brazil for its OSD manufacturing facility and Hormone manufacturing facility, both located at Bhayla, Ahmedabad.
